These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 833600)

  • 21. A comparison between fluorometric and mass fragmentographic determinations of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Sjöquist B; Johansson B
    J Neurochem; 1978 Sep; 31(3):621-5. PubMed ID: 576110
    [No Abstract]   [Full Text] [Related]  

  • 22. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
    Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 25. Visual averaged evoked responses (aer) and monoamine metabolites in cerebrospinal fluid (csf).
    Gottfries CG; Perris C; Roos BE
    Acta Psychiatr Scand Suppl; 1974; 255():135-42. PubMed ID: 4533705
    [No Abstract]   [Full Text] [Related]  

  • 26. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
    Majchrzak H; Kmieciak-Kołada K; Herman Z; Wencel T
    Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients.
    Post RM; Goodwin FK
    Arch Gen Psychiatry; 1974 Feb; 30(2):234-9. PubMed ID: 4809930
    [No Abstract]   [Full Text] [Related]  

  • 29. Similar effects of tryptophan and sleep on cisternal cerebrospinal fluid 5-hydroxyindoleacetic and homovanillic acids in cats.
    Radulovacki M; Buckingham RL; Chen EH; Kovacević R
    Brain Res; 1977 Jul; 129(2):371-4. PubMed ID: 884510
    [No Abstract]   [Full Text] [Related]  

  • 30. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
    Curzon G; Kantamaneni BD; Bartlett JR; Bridges PK
    J Neurochem; 1976 Mar; 26(3):613-5. PubMed ID: 4585
    [No Abstract]   [Full Text] [Related]  

  • 31. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J; Sharpe D; Curzon G
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in sleep disorders, epilepsy, degenerative chorea and acute cerebral vascular diseases].
    Livrea P
    Acta Neurol (Napoli); 1976; 31(5):580-600. PubMed ID: 138342
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid.
    Gateless D; Stanley M; Träskman-Bendz L; Gilroy J
    Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808
    [No Abstract]   [Full Text] [Related]  

  • 34. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
    Van Kammen DP; Marder SR; Murphy DL; Bunney WE
    Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 37. Biogenic amines in 47, XYY syndrome.
    Bioulac B; Benezech M; Renaud B; Roche D; Noël B
    Neuropsychobiology; 1978; 4(6):366-70. PubMed ID: 692839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of cerebrospinal monoamine metabolites in children using the probenecid method.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Isr Ann Psychiatr Relat Discip; 1977; 15(1):47-57. PubMed ID: 268307
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of high-performance liquid chromatographic, gas chromatographic--mass spectrometric, and fluorometric methods for the determination of homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.
    Anderson GM; Bowers MB; Roth RH; Young JG; Hrbek CC; Cohen DJ
    J Chromatogr; 1983 Oct; 277():282-6. PubMed ID: 6196374
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
    Gaillard JM; Constantinidis J; Tissot R
    Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.